Preventive Effect of Boiogito on Metabolic Disorders in the TSOD Mouse, a Model of Spontaneous Obese Type II Diabetes Mellitus
Figure 3
Effects of Boiogito on fat accumulation in TSOD and TSNO mice. (a) Total amounts of visceral and subcutaneous fat at 8 weeks after starting the experiment. (b) By-site accumulation of visceral and subcutaneous fat at 8 weeks after starting the experiment Filled diamond: TSOD control, filled square:TSOD Boiogito 1%, filled triangle: TSOD Boiogito 3%, open diamond: TSNO control, open square: TSNO Boiogito 1%, open triangle: TSNO Boiogito 3%. Data represent the mean ± SD of five to seven animals. *P < .05, **P < .01, significant differences from the TSOD control group. #P < .05, ##P < .01, significant differences from the TSNO control group.
